annual cash & cash equivalents:
$288.27M-$165.67M(-36.50%)Summary
- As of today (June 22, 2025), IDXX annual cash & cash equivalents is $288.27 million, with the most recent change of -$165.67 million (-36.50%) on December 31, 2024.
- During the last 3 years, IDXX annual cash & cash equivalents has risen by +$143.81 million (+99.56%).
- IDXX annual cash & cash equivalents is now -36.50% below its all-time high of $453.93 million, reached on December 31, 2023.
Performance
IDXX Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$163.97M-$124.30M(-43.12%)Summary
- As of today (June 22, 2025), IDXX quarterly cash & cash equivalents is $163.97 million, with the most recent change of -$124.30 million (-43.12%) on March 31, 2025.
- Over the past year, IDXX quarterly cash & cash equivalents has dropped by -$233.46 million (-58.74%).
- IDXX quarterly cash & cash equivalents is now -63.88% below its all-time high of $453.93 million, reached on December 31, 2023.
Performance
IDXX quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
IDXX Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -36.5% | -58.7% |
| 3 y3 years | +99.6% | -19.9% |
| 5 y5 years | +219.1% | +101.5% |
IDXX Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -36.5% | +156.1% | -63.9% | +65.3% |
| 5 y | 5-year | -36.5% | +219.1% | -63.9% | +101.5% |
| alltime | all time | -36.5% | +2999.6% | -63.9% | +7353.2% |
IDXX Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $163.97M(-43.1%) |
| Dec 2024 | $288.27M(-36.5%) | $288.27M(-6.6%) |
| Sep 2024 | - | $308.64M(-23.1%) |
| Jun 2024 | - | $401.59M(+1.0%) |
| Mar 2024 | - | $397.43M(-12.4%) |
| Dec 2023 | $453.93M(+303.3%) | $453.93M(+36.9%) |
| Sep 2023 | - | $331.70M(+149.7%) |
| Jun 2023 | - | $132.84M(+19.3%) |
| Mar 2023 | - | $111.37M(-1.0%) |
| Dec 2022 | $112.55M(-22.1%) | $112.55M(+13.5%) |
| Sep 2022 | - | $99.18M(-13.3%) |
| Jun 2022 | - | $114.36M(-44.1%) |
| Mar 2022 | - | $204.62M(+41.6%) |
| Dec 2021 | $144.45M(-62.4%) | $144.45M(-0.5%) |
| Sep 2021 | - | $145.20M(-37.4%) |
| Jun 2021 | - | $232.13M(-33.9%) |
| Mar 2021 | - | $351.16M(-8.5%) |
| Dec 2020 | $383.93M(+325.0%) | $383.93M(+118.7%) |
| Sep 2020 | - | $175.59M(+66.8%) |
| Jun 2020 | - | $105.29M(+29.4%) |
| Mar 2020 | - | $81.39M(-9.9%) |
| Dec 2019 | $90.33M(-27.0%) | $90.33M(-13.1%) |
| Sep 2019 | - | $104.00M(-6.2%) |
| Jun 2019 | - | $110.84M(-4.9%) |
| Mar 2019 | - | $116.62M(-5.8%) |
| Dec 2018 | $123.79M(-34.0%) | $123.79M(-15.7%) |
| Sep 2018 | - | $146.88M(-15.9%) |
| Jun 2018 | - | $174.56M(+9.6%) |
| Mar 2018 | - | $159.23M(-15.2%) |
| Dec 2017 | $187.68M(+21.2%) | $187.68M(+11.0%) |
| Sep 2017 | - | $169.02M(+1.8%) |
| Jun 2017 | - | $165.97M(+3.5%) |
| Mar 2017 | - | $160.41M(+3.6%) |
| Dec 2016 | $154.90M(+20.1%) | $154.90M(+3.2%) |
| Sep 2016 | - | $150.07M(+6.3%) |
| Jun 2016 | - | $141.14M(+6.2%) |
| Mar 2016 | - | $132.95M(+3.1%) |
| Dec 2015 | $128.99M(-60.0%) | $128.99M(-8.6%) |
| Sep 2015 | - | $141.15M(-13.5%) |
| Jun 2015 | - | $163.15M(-10.4%) |
| Mar 2015 | - | $182.16M(-43.5%) |
| Dec 2014 | $322.54M(+15.6%) | $322.54M(+10.2%) |
| Sep 2014 | - | $292.74M(-4.0%) |
| Jun 2014 | - | $305.05M(+6.6%) |
| Mar 2014 | - | $286.20M(+2.6%) |
| Dec 2013 | $279.06M(+24.6%) | $279.06M(+5.4%) |
| Sep 2013 | - | $264.81M(+5.5%) |
| Jun 2013 | - | $251.01M(+9.9%) |
| Mar 2013 | - | $228.36M(+2.0%) |
| Dec 2012 | $223.99M(+21.8%) | $223.99M(+1.1%) |
| Sep 2012 | - | $221.44M(+9.7%) |
| Jun 2012 | - | $201.81M(+8.8%) |
| Mar 2012 | - | $185.49M(+0.9%) |
| Dec 2011 | $183.90M(+17.2%) | $183.90M(+1.3%) |
| Sep 2011 | - | $181.50M(+13.9%) |
| Jun 2011 | - | $159.40M(+3.9%) |
| Mar 2011 | - | $153.46M(-2.2%) |
| Dec 2010 | $156.91M(+47.0%) | $156.91M(+17.5%) |
| Sep 2010 | - | $133.51M(+13.2%) |
| Jun 2010 | - | $117.97M(+10.9%) |
| Mar 2010 | - | $106.35M(-0.4%) |
| Dec 2009 | $106.73M(+35.3%) | $106.73M(0.0%) |
| Sep 2009 | - | $106.73M(+2.9%) |
| Jun 2009 | - | $103.74M(+20.2%) |
| Mar 2009 | - | $86.30M(+9.4%) |
| Dec 2008 | $78.87M | $78.87M(-6.8%) |
| Sep 2008 | - | $84.59M(+12.4%) |
| Jun 2008 | - | $75.27M(+25.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2008 | - | $60.22M(-0.2%) |
| Dec 2007 | $60.36M(-2.1%) | $60.36M(+3.2%) |
| Sep 2007 | - | $58.51M(+18.0%) |
| Jun 2007 | - | $49.59M(-8.1%) |
| Mar 2007 | - | $53.94M(-12.5%) |
| Dec 2006 | $61.67M(-8.2%) | $61.67M(+21.0%) |
| Sep 2006 | - | $50.95M(+1.9%) |
| Jun 2006 | - | $50.02M(+41.6%) |
| Mar 2006 | - | $35.34M(-47.4%) |
| Dec 2005 | $67.15M(+42.4%) | $67.15M(+16.2%) |
| Sep 2005 | - | $57.77M(+10.3%) |
| Jun 2005 | - | $52.35M(+17.4%) |
| Mar 2005 | - | $44.58M(-5.5%) |
| Dec 2004 | $47.16M(-51.4%) | $47.16M(-67.8%) |
| Sep 2004 | - | $146.53M(-11.0%) |
| Jun 2004 | - | $164.66M(-8.8%) |
| Mar 2004 | - | $180.51M(+86.2%) |
| Dec 2003 | $96.94M(-14.8%) | $96.94M(-45.2%) |
| Sep 2003 | - | $176.86M(+16.8%) |
| Jun 2003 | - | $151.43M(+13.5%) |
| Mar 2003 | - | $133.45M(+17.3%) |
| Dec 2002 | $113.79M(+70.7%) | $113.79M(+8.2%) |
| Sep 2002 | - | $105.20M(+53.4%) |
| Jun 2002 | - | $68.57M(-15.8%) |
| Mar 2002 | - | $81.48M(+22.2%) |
| Dec 2001 | $66.67M(+44.9%) | $66.67M(-3.4%) |
| Sep 2001 | - | $69.04M(+39.5%) |
| Jun 2001 | - | $49.49M(+77.6%) |
| Mar 2001 | - | $27.87M(-39.4%) |
| Dec 2000 | $46.01M(-21.5%) | $46.01M(+18.8%) |
| Sep 2000 | - | $38.73M(-47.4%) |
| Jun 2000 | - | $73.65M(+7.7%) |
| Mar 2000 | - | $68.37M(+16.7%) |
| Dec 1999 | $58.58M(-46.3%) | $58.58M(-21.6%) |
| Sep 1999 | - | $74.70M(-30.3%) |
| Jun 1999 | - | $107.10M(+17.3%) |
| Mar 1999 | - | $91.30M(-16.3%) |
| Dec 1998 | $109.10M(+2.0%) | $109.10M(-21.3%) |
| Sep 1998 | - | $138.70M(+7.0%) |
| Jun 1998 | - | $129.60M(+19.0%) |
| Mar 1998 | - | $108.90M(+1.8%) |
| Dec 1997 | $107.00M(-16.2%) | $107.00M(+1.4%) |
| Sep 1997 | - | $105.50M(-11.5%) |
| Jun 1997 | - | $119.20M(+8.6%) |
| Mar 1997 | - | $109.80M(-14.0%) |
| Dec 1996 | $127.70M(-14.5%) | $127.70M(+1.8%) |
| Sep 1996 | - | $125.50M(-10.0%) |
| Jun 1996 | - | $139.40M(+8.3%) |
| Mar 1996 | - | $128.70M(-13.8%) |
| Dec 1995 | $149.30M(+492.5%) | $149.30M(-19.6%) |
| Sep 1995 | - | $185.80M(+489.8%) |
| Jun 1995 | - | $31.50M(-9.2%) |
| Mar 1995 | - | $34.70M(+37.7%) |
| Dec 1994 | $25.20M(+33.3%) | $25.20M(+22.3%) |
| Sep 1994 | - | $20.60M(-8.0%) |
| Jun 1994 | - | $22.40M(+1.4%) |
| Mar 1994 | - | $22.10M(+16.9%) |
| Dec 1993 | $18.90M(+9.9%) | $18.90M(-12.5%) |
| Sep 1993 | - | $21.60M(+0.5%) |
| Jun 1993 | - | $21.50M(+7.5%) |
| Mar 1993 | - | $20.00M(+16.3%) |
| Dec 1992 | $17.20M(+84.9%) | $17.20M(+30.3%) |
| Sep 1992 | - | $13.20M(+14.8%) |
| Jun 1992 | - | $11.50M(+422.7%) |
| Mar 1992 | - | $2.20M(-76.3%) |
| Dec 1991 | $9.30M | $9.30M(-9.7%) |
| Sep 1991 | - | $10.30M(-50.5%) |
| Jun 1991 | - | $20.80M |
FAQ
- What is IDEXX Laboratories annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for IDEXX Laboratories?
- What is IDEXX Laboratories annual cash & cash equivalents year-on-year change?
- What is IDEXX Laboratories quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for IDEXX Laboratories?
- What is IDEXX Laboratories quarterly cash & cash equivalents year-on-year change?
What is IDEXX Laboratories annual cash & cash equivalents?
The current annual cash & cash equivalents of IDXX is $288.27M
What is the all time high annual cash & cash equivalents for IDEXX Laboratories?
IDEXX Laboratories all-time high annual cash & cash equivalents is $453.93M
What is IDEXX Laboratories annual cash & cash equivalents year-on-year change?
Over the past year, IDXX annual cash & cash equivalents has changed by -$165.67M (-36.50%)
What is IDEXX Laboratories quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of IDXX is $163.97M
What is the all time high quarterly cash & cash equivalents for IDEXX Laboratories?
IDEXX Laboratories all-time high quarterly cash & cash equivalents is $453.93M
What is IDEXX Laboratories quarterly cash & cash equivalents year-on-year change?
Over the past year, IDXX quarterly cash & cash equivalents has changed by -$233.46M (-58.74%)